Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Alzheimer's Disease

Recent news which mentions Alzheimer's Disease

< Previous 1 2 3 Next >
Alzheimer's treatment Leqembi could cost Medicare up to $5 billion per year, study estimates
Tags Politics Biotech and Pharmaceuticals Policy
From CNBC.com News
FDA commissioner praises Eli Lilly Alzheimer's treatment results
Tags Policy U/S/ Economy Eli Lilly and Co
From CNBC.com News
Eli Lilly Alzheimer’s treatment donanemab slowed disease progression in clinical trial
Tags Business Science Alzheimer's disease
From CNBC.com News
Biogen isn't concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says
Tags Alzheimer's disease Science Pharmaceuticals
From CNBC.com News
March 2023 Miscellany
Tags lung cancer Prostate Cancer Doc Gumshoe
From Stock Gumshoe
Getting Back to You on Anavex, Cassava, metformin and more
Tags Alzheimer's Disease Eisai (ESALY) Doc Gumshoe
From Stock Gumshoe
Relevant Updates – December 2022
Tags Biogen Idec (BIIB) influenza Eisai (ESALY)
From Stock Gumshoe
Roche's Another Alzheimer's Hopeful Flops In Phase 3 Program, Second Trial Setback Within Months
Tickers MOR RHHBF RHHBY RHHVF
Tags Briefs MOR Alzheimer's disease
From Benzinga
A brain expert shares his 7 'hard rules' for boosting memory and fighting off dementia
Tags Lifestyle Exercise Make It / Life
From CNBC.com News
Study Shows Positive Results In Patients With Alzheimer's Disease And Agitation
Tickers SPRC
Tags Health Care Penny Stocks News
From Benzinga
Odd & Ends – October 2022
Tags Eisai (ESALY) ALS / Lou Gehrig's Disease Alzheimer's Disease
From Stock Gumshoe
These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win
Tickers ABOS ACIU ALZN ANVS
Tags ACIU ABOS Small Cap
From Benzinga
Alzheimer's Progression Slowed Down By Biogen's New Drug In Late-Stage Study: Analyst Sees 25% Upside For Stock
Tickers BIIB ESALY
Tags Marc Goodman Analyst Ratings BIIB
From Benzinga
Following Up on Your Suggestions – September 2022
Tickers DIET
Tags Rheumatoid Arthritis Impax Laboratories (IPXL) Alzheimer's Disease
From Stock Gumshoe
Alzheimer's Disease: A New Generation of Screenings and Therapies on the Horizon
Tickers DGX
Tags Research, Reports & Publications Health & Healthcare NYSE:DGX
From 3BL Media: Corporate Social Responsibility, Energy and Health News
EXCLUSIVE: Cognition Therapeutics Shares Biomarker Data From Alzheimer's Candidate
Tickers CGTX
Tags Biotech Health Care Penny Stocks
From Benzinga
Alzheimer’s Drug Development — July Responses to Questions & Requests
Tags Doc Gumshoe Dundee Corp (DC/A/TO DDEJF) Cassava Sciences (SAVA)
From Stock Gumshoe
AbbVie Dumps An Early-Alzheimer's Candidate Developing In Collaboration With Alector
Tickers ABBV ALEC
Tags Briefs Biotech Benzinga
From Benzinga
Alzheimer’s Disease June 2022 – Possible Signs of Progress
Tags Guest Articles TauRX Pharmaceuticals Alzheimer's Disease
From Stock Gumshoe
Researchers Investigate New Treatment Pathways For Alzheimer's After Commercial Failure Of Biogen's Aduhelm
Tickers BIIB
Tags Alzheimer's disease Benzinga Health Care
From Benzinga
Alzheimer’s Disease May 2022 – Is There Anything New?
Tags inflammation Doc Gumshoe Eisai (ESALY)
From Stock Gumshoe
Eisai - Biogen Seek Accelerated Approval For Their Second Alzheimer's Drug
Tickers BIIB ESALF ESALY
Tags Market News General BIIB
From Benzinga
New York Times Report Fresh Allegations On Cassava's Simufilam Alzheimer's Trials, Shares Fall
Tickers SAVA
Tags SAVA Alzheimer's disease Benzinga
From Benzinga
EXCLUSIVE: Longeveron Adds Miami Veterans Affairs Site To Its Ongoing Mid-Stage Alzheimer's Trial
Tickers LGVN
Tags News Exclusives Health Care
From Benzinga
Biogen's Alzheimer's Drug Aduhelm Medicare Coverage Restricted To Just Clinical Trials, CMS Finalizes
Tickers BIIB
Tags Alzheimer’s News Top Stories
From Benzinga
EXCLUSIVE: Longeveron's Lomecel-B Data In Alzheimer's Disease Published In Medical Journal
Tickers LGVN
Tags LGVN Market News News
From Benzinga
Biogen, Eisai Unveil New Data On Another Alzheimer's Candidate, Lecanemab
Tickers BIIB ESALF ESALY
Tags BIIB Market News News
From Benzinga
Biogen Shares Aduhelm Data In Alzheimer's Disease At 128 Weeks
Tickers BIIB
Tags Market News BIIB General
From Benzinga
Prothena Highlinghts New Preclinical Data For Alzheimer's, Parkinson's Vaccine Programs
Tickers PRTA
Tags Market News Preclinical Phase Parkinson’s Disease
From Benzinga
Gain Therapeutics Posts Encouraging Preclinical Data From Parkinson's, Alzheimer's Programs
Tickers GANX
Tags Market News Parkinson’s Disease Preclinical Phase
From Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.